| Literature DB >> 35416514 |
Şeyhmus Külahçıoğlu1, Işıl Kutlutürk Karagöz2, Yusuf Bilen3, Barkın Kültürsay3, Ravza Betül Akbaş3, Enver Yücel4, Hacer Ceren Tokgöz3, Abdülkadir Uslu3, Ali Karagöz3, Cihangir Kaymaz3,4.
Abstract
BACKGROUND: Left ventricular systolic dysfunction (LVSD) may develop without coronary artery disease, hypertension (HT), or valvular pathologies in patients with diabetes mellitus (DM), which is defined as diabetic cardiomyopathy (DCM) and its pathophysiology is still unclear. Diabetic retinopathy (DR) is a microvascular complication of DM, and patients with DR have increased risk for the development of heart failure (HF). Two-dimensional speckle tracking echocardiography (2D-STE) evaluates longitudinal deformation in left atrium (LA) myocardium and previous studies utilizing 2D-STE have revealed the detrimental effects of DM on LA functions. Although some studies have shown the association between DR and left ventricle (LV) systolic functions, as far as the researchers of this study investigated, there is no study evaluating the relationship between LA deformation parameters and DR. Hence, we aimed to investigate the relationship between the presence and the degree of DR and LA deformation parameters.Entities:
Keywords: Diabetic retinopathy; Left atrial contractile strain; Speckle tracking echocardiography
Year: 2022 PMID: 35416514 PMCID: PMC9008098 DOI: 10.1186/s43044-022-00265-x
Source DB: PubMed Journal: Egypt Heart J ISSN: 1110-2608
Comparison of baseline clinical and laboratory parameters in diabetics with normal retina versus retinopathy
| Variable | Normal Retina, ( | Retinopathy present, ( | |
|---|---|---|---|
| Age, (years) | 52.6 (9.3) | 55.4 (10.3) | 0.09 |
| Gender (Female), | 36 (66.7) | 62 (53.4) | 0.14 |
| HT, | 36 (66.7) | 68 (58.6) | 0,40 |
| Systolic BP (mm Hg) | 135.3 (15.8) | 137.6 (19.4) | 0.44 |
| Diastolic BP (mm Hg) | 79.1 (10.4) | 82.9 (12.6) | 0.06 |
| Smoking, | 8 (14.8) | 42 (36.2) | 0.008 |
| Lipid lowering therapy, | 22 (40.7) | 18 (15.5) | 0.001 |
| Glucose (mg/dL) | 161 (53.7) | 235 (93.5) | < 0.001 |
| Creatinine (mg/dL) | 0.8 (0.3) | 0.9 (0.3) | 0.03 |
| Albumin (mg/dL) | 4.3 (0.4) | 4.5 (0.4) | 0.04 |
| LDL (mg/dL) | 91.5 (23.7) | 121.4 (46.3) | 0.004 |
| TSH (mIU/L) | 1.5 (0.7) | 1.9 (0.5) | 0.52 |
| Microalbumin/creatinine (spot urine) | 7.60 (3.60) | 19.4 (10.5) | < 0.001 |
| WBC (103/µL) | 7.1 (1.6) | 7.7 (1.7) | 0.46 |
| Hemoglobin (g/dL) | 12.5 (1.5) | 13.1 (1.4) | 0.005 |
| HbA1c (%) | 7.30 (0.9) | 8.9(1.9) | < 0.001 |
| hs-CRP (mg/L) | 0.6 (0.7) | 0.6 (0.8) | 0.74 |
Continuous variables are presented as mean and standard deviation (SD)
BP, Blood pressure; LDL, low-density lipoprotein; TSH, Thyroid stimulating hormone; WBC, White blood cell; hs-CRP, High sensitive C-reactive protein
Comparison of basic echocardiographic parameters in diabetics with normal retina vs. retinopathy
| Variables | Normal retina, ( | Retinopathy present, ( | |
|---|---|---|---|
| LV septal wall (cm) | 1.1 (0.1) | 1.1 (0.1) | 0.11 |
| LV posterior wall (cm) | 1 (0.1) | 1.1 (0.1) | 0.03 |
| End-diastolic diameter | 4.7 (0.4) | 4.6 (0.5) | 0.13 |
| End-systolic diameter | 2.9 (0.3) | 2.9 (0.5) | 0.85 |
| End-diastolic volume, 4CH | 87.6 (20.6) | 89.2 (27) | 0.69 |
| End-systolic volume, 4CH | 38.8 (10.6) | 40.9 (18) | 0.43 |
| LVEF (Teicholtz) | 67.6 (7.5) | 66.2 (8.7) | 0.34 |
| LVEF (Biplane Simpson) | 55.2 (6.1) | 52.9 (7.8) | 0.07 |
| TAPSE (mm) | 23 (2) | 22 (4) | 0.006 |
| MAPSE (mm) | 13 (2) | 12 (2) | 0.004 |
| E value | 0.70 (0.62, 0.79) | 0.65 (0.55, 0.78) | 0.28 |
| A value | 0.80 (0.67, 0.90) | 0.90 (0.75, 1.0) | 0.04 |
| LAVI (mL/m2) | 42.7 (31.8, 49.8) | 44.7 (36.1, 53) | 0.19 |
| Dt (m/s) | 245 (39) | 239 (46) | 0.39 |
| LV twist | 20.8 (7.7) | 19.4 (6.2) | 0.22 |
| GLS | − 18.9 (2.1) | − 17.8 (2.7) | 0.008 |
Continuous variables are presented as mean and standard deviation (SD)
LV, Left ventricle; 4CH, Four-chamber; LVEF, Left ventricle ejection fraction; TAPSE, Tricuspid annular plane systolic excursion; MAPSE, Mitral annular plane systolic excursion; LAVI, Left atrial volume index; Dt, Deceleration time; GLS, Global longitudinal strain
Fig. 1Three-dimensional plot for predicting LA conduit function according to DR presence and age
Fig. 2Density histogram of LA contractile strain values of the three groups
Comparison of advanced echocardiographic parameters in diabetics with normal retina versus non-proliferative and proliferative retinopathy
| Variables | Normal retina, ( | Non-proliferative retinopathy present, ( | Proliferative retinopathy present, ( | |
|---|---|---|---|---|
| LAVI (mL/m2) | 42.6 (14.1) | 46 (13.3) | 53 (25) | 0.006 |
| E Mitral | 0.7 (0.1) | 0.7 (0.2) | 0.7 (0.2) | 0.07 |
| A Mitral | 0.8 (0.2) | 0.9 (0.2) | 1 (0.2) | 0.10 |
| LA strain rate S | 1.5 (0.4) | 1.2 (0.3) | 1.1 (0.3) | 0.01 |
| LA strain rate E | − 1.2 (0.6) | − 0.9 (0.5) | − 0.9 (0.5) | 0.01 |
| LA strain rate A | − 1.7 (0.6) | − 1.5 (0.6) | − 1.7 (0.6) | 0.19 |
| LA strain conduit | 30.1 (6.6) | 25.3 (6.5) | 22.9 (4.9) | < 0.001 |
| LA strain reservoir | 14.2 (3.6) | 12.2 (4.1) | 13 (3.7) | 0.04 |
| LA strain contractile | 15.9 (6.8) | 13.1 (7.4) | 9.9 (4.7) | < 0.001 |
Continuous variables are presented as mean and standard deviation (SD)
LAVI, Left atrial volume index; LA, Left atrium
Proportional odds regression model for predicting LA contractile strain function
| Variables | Odds ratio | Confidence interval | |
|---|---|---|---|
| Age (from 44 to 75 years) | 2.07 | 0.72–5.89 | 0.17 |
| HbA1c (%) (7.2 to 9.4) | 1.09 | 0.72–1.64 | 0.66 |
| Systolic BP (mmHg) (125 to 150) | 0.90 | 0.61–1.31 | 0.58 |
| Creatinine (mg/dL) (0.7 to 1) | 0.71 | 0.51–0.99 | 0.04 |
| Retinopathy presence | 0.24 | 0.11–0.50 | 0.001 |
| GLS (− 19.9 to − 16.6) | 0.79 | 0.53–1.18 | 0.26 |
| LAVI (mL/m2) (33.5 to 52.6) | 0.62 | 0.43–0.89 | 0.01 |
BP, Blood pressure; LAVI, Left atrial volume index; GLS, Global longitudinal strain